Affymetrix GeneChips are one of the best established microarray platforms. This powerful technique allows users to measure the expression of thousands of genes simultaneously. However, a microarray experiment is a sophisticated and time consuming endeavor with many potential sources of unwanted variation that could compromise the results if left uncontrolled. Increasing data volume and data complexity have triggered growing concern and awareness of the importance of assessing the quality of generated microarray data. In this review, we give an overview of current methods and software tools for quality assessment of Affymetrix GeneChip data. We focus on quality metrics, diagnostic plots, probe-level methods, pseudo-images, and classification methods to identify corrupted chips. We also describe RNA quality assessment methods which play an important role in challenging RNA sources like formalin embedded biopsies, laser-micro dissected samples, or single cells. No wet-lab methods are discussed in this paper.
INTRODUCTION

A
FFYMETRIX GENECHIPS 1 are among the most widely used tools to analyze gene expression on a genomewide scale (Ueda et al., 2004) . Other important applications comprise genomic re-sequencing (Hacia, 1999) , genotyping (Lips et al., 2005) , genome-wide exon-level analysis (Sugnet et al., 2006) , and transcript mapping (Kapranov et al., 2005) . Microarray technology offers the unprecedented opportunity to measure gene expression in relation to physiological and environmental factors and has great potential for clinical and pharmacological applications (Borovecki et al., 2005; Chicurel and Dalma-Weiszhausz, 2002) . To gain optimal benefit from this technology, both experiment and analysis have to be carefully planned and conducted. Usually, microarray analysis starts with quantifying significant changes in gene expression, often followed by the identification of genes with correlated expression profiles, regulatory networks, or involved biological pathways. Measuring gene expression with Affymetrix GeneChip microarrays is a sophisticated and time consuming process, which often involves many experimental steps. Unwanted variability introduced by manufacturing, sample handling, or experiment setup might affect data quality severely and mask the effect of the investigated experimental factors on the gene expression profile. Excluding a few lowquality chips from the subsequent data analysis might increase the number of differentially expressed genes, while simultaneously decreasing the expected false discovery rate in the identified candidate list (Heber et al., 2006) . The result is a significant increase in biologically meaningful conclusions. According to our experience, one or few corrupted chips can render the analysis of a microarray experiment worthless. The experiment might then lead to the insight that the invested effort was wasted, or even worse, wrong conclusions might be drawn. Therefore, quality control is critical for any subsequent data analysis, and every sound microarray analysis should start with an appropriate quality assessment.
To gain optimal information from microarray data it is also necessary to know about all relevant experimental factors like treatment, or utilized RNA extraction protocols. The issue standardized meta data was first addressed by Brazma et al. (2001) when they proposed a guideline for the Minimum Information About a Microarray Experiment (MIAME), which is required to ensure that microarray experiments can be easily interpreted and independently verified. With more and more multi-chip and multi-centre projects, and steadily growing data exchange via public data bases (Brazma et al., 2003b; Edgar et al., 2002; Hermida et al., 2006; Ikeo et al., 2003) , standardized meta data also becomes increasingly important for quality control (Brazma et al., 2003a) . However, in this review we will not discuss the quality of meta-data but rather focus on GeneChip raw data. Unfortunately, quality assessment is complex for extremely high-dimensional microarray data. Our goal in this paper is to give GeneChip users an overview of state of the art quality assessment methods along with a guideline of how to use them. Due to the abundance of available tools, this review cannot be exhaustive. We will focus on methods for assessing RNA degradation from GeneChip raw data, quantitative modeling on the probe level, and diagnostic plots. We will also discuss automated procedures to detect problematic chips, a topic which becomes more and more important with continuously growing data volume.
BACKGROUND
The following sections provide background knowledge necessary to understand the described quality assessment methods.
Affymetrix GeneChip technology
Affymetrix oligonucleotide chips (Lipshutz et al., 1999; Lockhart et al., 1996) consist of up to a few millions of probe cells, each containing several hundred thousands of oligonucleotide probes (www.affymetrix.com). A set of 11-20 different 25-mer oligonucleotide probe-pairs is used to measure a specific transcript in an RNA sample. Each probe-pair consists of a perfect match (PM) probe and a mismatch (MM) probe, which is identical with the PM probe except that the middle base is substituted with its complement. The PM probe is designed to specifically hybridize transcripts from the targeted gene while the MM probe measures non-specific hybridization. After hybridization and labelling, a fluorescence scanning image is recorded and stored in a DAT file. Affymetrix GeneChip Operating Software (GCOS) uses DAT files to estimate the intensities for each probe on the chip, and stores the results in a CEL file. The group of CEL files which corresponds to the different hybridizations is the starting point for the subsequent statistical analysis.
Sources of variation
Investigators are often only interested in the effect of the planned experimental factors, such as drugtreatment or diet. However, different sources of variation originating from biological, and technical causes contribute to observed expression level changes and can mask the effect of interest (Churchill, 2002) . Biological variation reflects true variation among experimental units like healthy and diseased subjects, or different tissues. Biological variation can be caused by different experimental factors (e.g., keepers, gender of the laboratory animals, temperature differences of different incubators) and the need to be controlled by an appropriate experimental design (Dumur et al., 2004; Zakharkin et al., 2005) . Technical variations comprise all sources of variability which may arise during sample processing. They should be avoided as far as possible and they have to be assessed by different quality checks. Different studies report different main contributors of biological transcript level variation caused by tissue heterogeneity and differences between QUALITY ASSESSMENT OF AFFYMETRIX GENECHIP DATA individual patients (Bakay et al., 2002) , differences within and among populations of adult Fundulus fish (Oleksiak et al., 2002) , or day-to day variation (Dumur et al., 2004) . Since Affymetrix GeneChip production, hardware, and protocols are highly standardized, technical variation is usually expected to be low compared to biologically induced variability, given that appropriate care was taken during sample generation (Reimers et al., 2005; Zakharkin et al., 2005) .
Data preprocessing
Preprocessing methods are required to get from the observed fluorescent intensity signals measured on each probe cell to the desired gene-wise expression levels. Preprocessing usually involves three steps: (1) background adjustment, which divides the measured hybridization intensities into a background, and a signal component, (2) summarization which combines probe-level data into gene expression values, and (3) normalization which has the aim of removing non-biological variation between arrays. Various alternative preprocessing methods have been developed, among them the most prominent are, dChip (Li and Wong, 2001; Schadt et al., 2001) , RMA (Irizarry et al., 2003a; Irizarry et al., 2003b) , gcRMA (Wu et al., 2004) , and from Affymetrix MAS5 and PLIER. The choice of one of these methods can have enormous impact on the ultimate result. For example, in a study conducted by Zakharkin et al. (2005) , the biological variation was the strongest source of variation when dChip and RMA were used; when using MAS 5 or GCRMA-EB the residual variation, which could neither be assigned to biological variation nor to labeling effects, was the most important source of variation. Most studies find RMA to be among the best methods with respect to precision. However, conflicting reports have been published concerning the accuracy and overall performance of different preprocessing methods (Bolstad et al., 2003; Cope et al., 2004; Hu and Willsky, 2006; Millenaar et al., 2006; Ploner et al., 2005; Qin et al., 2006; Shedden et al., 2005; Verhaak et al., 2006 ). The raw probe-level data, the gene-wise expression levels, and the byproducts (e.g., weights and residuals) obtained from different preprocessing methods are used for quality assessment.
QUALITY ASSESSMENT METHODS
In the field of microarray data analysis, most researchers use operational quality definitions. Microarray data is assumed to be of good quality if it is possible to extract the information of interest; for example, the gene expression response to a stimulus. Additionally, unnecessary variability is seen as an indication of low quality. It is essential to start the quality assurance procedure already with a careful experimental design which controls different sources of variation. An accurate sample processing is of similar importance and should be monitored by different quality checks of the sample before hybridization. The analysis of the generated raw data should then begin with a sound quality assessment to identify corrupted chips. In practice, quality metrics are highly dependent on the experimental context. Certain quality values might be acceptable in the context of a challenging animal experiment, whereas in the context of a more homogeneous cell-line experiment the same chip would be rejected. Overall consistency between samples in an experiment is often more important than absolute QC parameter values themselves (Gentleman et al., 2005) .
In recent years, a great effort has been made to develop methods to assess and visualize quality of GeneChip data. In this review, we mainly focus on those methods which are, in our opinion, most important for a successful quality assessment. Therefore, we rely on our experience gained in the context of the bioinformatics service within the DNA array facility of the University of Lausanne (DAFL). After analyzing several hundreds of GeneChips, and gaining extensive experience with various quality assessment methods, we have developed, and partly automated, a standardized quality assessment procedure on GeneChip raw data (Heber et al., 2006) . Quality assessment usually starts with a careful inspection of the scan images, the grid alignment, and the Affymetrix quality control metrics. Subsequently, different diagnostic plots are utilized to get insight in potential RNA degradation or general sample quality problems, as well as possible trouble during the hybridization, labeling or scanning. We also perform a robust multi-chip probelevel fit across all chips in order to identify aberrant chips by analyzing the derived weights and residuals. If one or few chips look suspicious in regard of any of these quality metrics, we recommend performing the whole analysis twice-once with and once without-the suspicious chips. From the obtained results, it HEBER AND SICK is often possible to judge if the exclusion of the chips has improved the result (e.g., by checking the list and number of differentially expressed genes, the estimated false discovery rate) (Storey, 2002 (Storey, , 2003 , or the ultimate biological meaning. In the following sections, we will describe the involved methods and software tools in greater detail.
Affymetrix quality control metrics
Affymetrix GeneChip Operating Software (GCOS) provides a collection of quality control metrics together with guidelines on how to use them (Table 1) . Moreover, Affymetrix suggests checking the produced scan image for artifacts. Subsequently, it should be verified that the automatically performed grid alignment did work correctly by using internal spikes (biotinylated B2) which mark the outer boundary, the checkerboard structure, and the array name.
These quality metrics are a good starting point for quality control. However, none of these metrics uses values connected to derived expression levels, and therefore a link to the most important numbers is missing here.
Diagnostic plots
Due to the high-dimensional and complex nature of GeneChip data, exploratory visualization is an essential tool in detecting quality problems. The diagnostic plots described below are routinely used to monitor GeneChip data quality (Gentleman et al., 2005) . All plots were generated using the statistical language R (Table 2 ). They rely on data from 6 Affymetrix HGU133A chips comparing placenta and testis RNA within an internal project of the DAFL, see (Heber et al., 2006; Psarros et al., 2005) for a more detailed description.
Intensity plots. A typical first check controls the scan image of individual GeneChips for regional biases and other spatial artifacts. Since the distribution of hybridization intensities might be highly skewed, sometimes spanning several orders of magnitudes, one often visualizes log transformations of the intensity values to reveal potential artifacts (Fig. 1a,b) . A boxplot is another powerful tool to summarize intensity distributions. Boxplots are easy to compare and they pinpoint outliers in spread and location (Fig. 2a) . Such outliers are often caused by differences in amplification or labeling. Smaller discrepancies might be sufficiently removed by normalization, but in more serious cases, correction is not possible and the chip should be removed (Fig. 2b) .
QUALITY ASSESSMENT OF AFFYMETRIX GENECHIP DATA 361 MvA plots. An MvA plot of two arrays displays, for each gene, the difference M ϭ E 2 Ϫ E 1 of the logexpression value E 1 (of array 1) and E 2 (of array 2) on the y-axis against the average expression A ϭ (E 1 ϩE 2 )/2 of this gene on the x-axis. The presented MvA plot visualizes gene expression change versus the average gene expression (Fig. 3a) . Often, the intensity dependent median M is added to the plot as a smooth curve, providing a sense of relative shift in log intensities between the two arrays. In a large multichip experiment, one can reduce the number of MvA plots by comparing each chip against a single synthetic data set created from feature-wise medians instead of displaying all chip pairs. Boxplots of chip-wise derived M values can also facilitate comparisons between many chips by ignoring potential dependencies on the average gene expression level (Fig. 4b) . MvA plots, which are not centered or which differ from the other MvA plots in spread, might indicate an aberrant chip. Since most experimental designs rely on biological replicates, this deviation is often not due to controlled experimental factors, but rather due to introduced unwanted variation.
RNA degradation plots. RNA preparation and labeling are probably the most critical and laborious steps in the experimental workflow, and RNA quality can have enormous impact on the generated mi-HEBER AND SICK # read in raw data; perform a robust multi-chip probe-level fit raw <-ReadAffy(); norm <-rma(raw); expr <-exprs(norm); Pda <-fitPLM(raw, modelϭPM ϳ Ϫ1 ϩ probes ϩ samples); # image plots for raw data and log-scaled data and residuals: image(raw [,5 croarray data. Therefore, it is highly recommended to assure RNA integrity before the hybridization step, for example, by checking the electrophoresis trace of the extracted RNA. See (Dumur et al., 2004) for an excellent overview of quality assessment methods for samples before hybridization to a GeneChip. Fortunately, RNA integrity can also be assessed from the GeneChip raw data. Since RNA degradation characteristically starts from the 5Ј end, one expects that 5Ј end probes show lower intensities than 3Ј end probes. However, 3Ј to 5Ј probe intensity ratios can be quite variable, dependent on probe affinity differences within a probe-set. Therefore, a 3Ј to 5Ј trend can only be detected after averaging over a large number of genes. RNA degradation plots (Gautier et al., 2004) 
FIG. 3.
MvA and degradation plot. (a) MvA plot showing intensity dependent expression differences for chip 5 compared with the "artificial" median chip derived from all six chips. The dashed line shows a smoothing spline fitted to the median M-value, revealing a deviation from the expected horizontal line at zero, and indicating that normalization was not able to cope with the deviating behavior of chip 5. (b) Degradation plot. Each curve corresponds to a single chip and visualizes the chip-averaged dependency between probe intensity and probe position. Corresponding slopes are listed in the legend given in the order of the shifted curves. Chip 3 shows a significantly smaller slope; chip 5 exhibits a slightly different shape compared to the average behavior.
"RNA digest plot" the probe intensity averaged over all probe-sets on the chip is plotted against probe position (Fig. 3b) . The result can be approximated by a linear curve. Experience shows that the slope and also the shape of this curve is characteristic for the used organism, chip-type and amplification protocol (Cope et al., 2006; Gentleman et al., 2005) . For example, an ascending curve with declining last 3Ј probe and overall slope close to 2 is typical for HG-U133A chips when using a single-round amplification (Fig. 3b) (Gentleman et al., 2005) . Much higher slopes may indicate RNA degradation, but the actual value is less important than agreement between chips. Typical causes for deviating slopes comprise poor sample handling, varying RNA quality, or changes in the RNA amplification procedure. Analyzing chips which show very different 3Ј to 5Ј trends is very likely to introduce extra bias into the experiment and should be avoided.
Pseudo images from probe level models
As mentioned above, some byproducts of the robust multi-chip analysis (RMA) preprocessing can also be used for quality assessment. RMA assumes the following linear model for the background adjusted normalized probe-level data Y jk of each probe-set i: Y jk ϭ ␤ j ϩ ␣ k ϩ ⑀ jk , where Y jk is the sum of a probe effect ␤ j and a chip effect ␣ k , and an error ⑀ jk . To make this model identifiable, the sum of the probe effects is constrained to be zero. The parameters ␣ k provide an index of expression for each chip.
The weights and residuals generated by the model fitting procedure can be used to generate quality diagnostics which have the advantage of being directly related to the quality of the expression measures produced (Irizarry et al., 2003a; Irizarry et al., 2003b) . Pseudo-images displaying the spatial distribution of the residuals, together with their sign, are often more informative than images of the raw probe intensities (Fig.  1c) . Observing small artifacts is quite common and usually not critical since the probes for any gene are distributed over the entire chip, and the robust approach automatically reduces the weight of deviating probes. A rule of thumb is to tolerate distortions in up to 20% of the chip area.
Boxplot representation of residuals and weights from probe level fits
The normalized unscaled standard error (NUSE) plot (Fig. 4b) visualizes the chip-wise distribution of standard error estimates obtained for each gene on each array when performing the robust multi-chip probelevel fit (see former section). Standardization accounts for the fact that variability might considerably differ between genes and assures that the median standard error across arrays is 1 for each gene. Aberrant chips can be easily identified by their increased median residuum. As rule of thumb, medians higher than 1.05 are alarming.
The relative log expression (RLE) plot compares the expression levels on each chip to an artificial median of all chips in the experiment. Often, it is reasonable to assume that despite biological variability, the majority of genes do not change their expression across experimental conditions. RLE boxplots are then expected to be centered on zero and to show a small inter-quartile range. Deviating boxplots often indicate problematic chips whose exclusion would be beneficial for further analysis, where the reasoning is the same as for deviating MvA plots.
Automated quality assessment
Despite the multiple quality controls described so far, simple criteria to distinguish high-and low-quality data are missing. This makes quality assessment extremely difficult, time-consuming, and often subjective. In many cases only an expert has the necessary knowledge to judge the multiple QC parameters, but in practice, the final decision about keeping or discarding a data set often has to be made by a user who is often not a specialist in microarray analysis. The situation becomes even more worrisome if one considers the continuously expanding amount of data (some experiments consist of more than 100 chips), and the numerous research groups involved in the same project. Automated objective quality assessment that emulates expert opinion would be highly desirable, but surprisingly little work has been done so far, see (Burgoon et al., 2005) for an overview. Purely variance-based statistical methods do not judge data based on prior knowledge, and suffer from a lack of training. Since these methods only test for deviation from the rest of the data, low-quality chips could escape detection if they belong to a large batch of low-quality data (Burgoon et al., 2005) . A Bayesian approach could help, but to the best of our knowledge, no such method exists. Methods based on sample clustering or multi-dimensional scaling (Reimers et al., 2005) determine whether samples exhibit similar behavior and assume that outliers are samples of dubious quality. These methods do not directly address the technical quality of the data and may yield false-negative results in the presence of extensive biological variation, similar to the purely variance based approaches. Supervised methods based on feature extraction and subsequent classification show good performance independent of the used classifier (Burgoon et al., 2005; Heber et al., 2006) , but they strongly depend on the availability of sample training data annotated by an expert.
Software tools
In general, the first software tool which is used when performing a GeneChip experiment is the GeneChip Operating Software (GCOS) from Affymetrix. GCOS automates the control of Fluidics Stations and Scanners, acquires data, manages sample and experimental information, and performs basic gene expression data analysis. For quality assessment, GCOS generates a report file containing the above discussed Affymetrix quality metrics.
Although there are many choices of software tools with very different capabilities in terms of the subsequent quality assessment available, we only have discussed methods which have been presented in peer reviewed publications. Most of these methods are accessible via software packages which have been developed in the framework of Bioconductor 2 (Gentleman et al., 2005) using the open source statistical language R (R Core, 2004) (http://www.R-project.org). For a much more detailed description of Bioinformatics solutions (including quality assessment of GeneChip data) using R and Bioconductor we refer the reader to the excellent book by Gentleman et al. (2005) .
The Bioconductor packages "simpleaffy" and "affyOCReport" were developed to bundle a series of widely accepted quality assessment methods (Wilson and Miller, 2005) . They use Affymetrix quality assessment parameters, as well as probe level methods and exploratory plots, which were originally developed within other Bioconductor packages such as "affy," "affyPLM," "dChip," and "limma." State of the art microar-QUALITY ASSESSMENT OF AFFYMETRIX GENECHIP DATA ray analysis can be performed very efficiently by using the powerful functions of these R packages. As an example we show here the R-script which was used to produce the basic content of the figures within this paper (Table 2) .
However, R is a script-based programming environment which requires some programming skills; therefore, experimentalists often prefer to access these tools via Bioconductor GUIs (e.g., limmaGUI and affylmGUI), or webtools like Expression Profiler at EBI, ArrayQuest (Argraves et al., 2005) , RACE (Psarros et al., 2005) , or Genevestigator (Zimmermann et al., 2004) .
Other widespread commercial statistical software environments like Matlab, Insightful Sϩ, or SAS provide partly similar functionality like R, and allow users to incorporate Bioconductor modules as a plug-in. Moreover, there exists a plethora of commercial software packages specialized in the analysis of genomic data which are beyond the scope of this review.
RESULTS AND DISCUSSION
Microarrays are a core technology for research and applications in the field of biology, toxicology, pharmacology, and medicine. To gain maximum benefit of this technology, one needs standards and quality measures to objectively assess the performance of the methods and the protocols used. It is essential to ensure that sample preparation and hybridization were performed correctly, and to discard corrupted GeneChips from further analyses. The importance of this task is reflected by a steadily growing number of publications and the launch of initiatives like the MicroArray Quality Control (MAQC) 3 project involving six FDA Centers, major providers of microarray platforms, EPA, NIST, academic laboratories, and other stakeholders. The effort spent on quality control will be directly rewarded by an increase in data integrity and reproducibility. Ultimately, this will result in more meaningful biological results and better knowledge-based decisions.
Although extremely important, we do not discuss assessment of sample quality before hybridization, or specialized applications like resequencing, tiling, or exon arrays. Starting from raw hybridization data stored in CEL files, we have described multiple quality control methods and software tools ranging from diagnostic plots to fully automated quality assessment systems which we believe will be of benefit for Affymetrix GeneChip users. Based on our experience, the combination of these methods produces a reliable and thorough quality assessment, which is well worth the effort to implement.
